Want to join the conversation?
Genetic testing tools company $ILMN reported a rise in 2Q16 earnings driven by notable strength across its sequencing consumable and array portfolios. Net income rose to $121.97MM or $0.82 per share from $102.25MM or $0.69 per share last year. Revenue grew to $600.12MM from $539.38MM. Non-GAAP EPS increased to $0.86 from $0.80.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.